News and insights
Good Clinical Trials Collaborative
Inside GoodTrials Newsletter – June 2023
Good Clinical Trials Collaborative
Highlights of this edition include our community response to ICH's Public Consultation on GCP E6(R3) Guideline and our commentary in Lancet Psychiatry - "Fast tracking informative clinical trials: lessons for mental health".
Professor Sir Martin Landray
“Time to turn words into action” – a response to O’Shaughnessy review
Professor Sir Martin Landray
Following Lord O’Shaughnessy’s new review into commercial clinical trials, Professor Sir Martin Landray has co-authored an article for The Lancet exploring how the UK can deliver on the recommendations outlined in the review.
Good Clinical Trials Collaborative
Public consultation on key global guideline for clinical trials launched
Good Clinical Trials Collaborative
The Good Clinical Trials Collaborative is organizing community response to ensure new guideline helps trials to be informative, ethical and efficient.
Good Clinical Trials Collaborative
New film reaffirms importance of good trials and good guidance
Good Clinical Trials Collaborative
The Good Clinical Trials Collaborative’s new film sees experts discuss the importance of high-quality trials in advancing global healthcare and the role of good guidance in influencing change.
Good Clinical Trials Collaborative
Celebrating Clinical Trials Day with new content series, #GoodTrialsGrapevine
Good Clinical Trials Collaborative
To commemorate Clinical Trials Day this year, we are kicking off a new content series, #GoodTrialsGrapevine, where we invite clinical trials experts and thought leaders to share their perspectives on key themes in clinical research; what makes a good trial and why.
Good Clinical Trials Collaborative
“Fast tracking informative clinical trials: lessons for mental health” – our commentary in Lancet Psychiatry
Good Clinical Trials Collaborative
Recent policy initiatives have called for clinical trials to be strengthened as a response to future pandemics. We argue that similar efforts must be made to improve the trials landscape for non-communicable diseases, particularly mental health.
Good Clinical Trials Collaborative
Inside Goodtrials Newsletter – February 2023
Good Clinical Trials Collaborative
The year ahead will see major initiatives take significant steps in shaping the future of clinical trials globally. From the anticipated public consultation on updated ICH Good Clinical Practice guidance to new World Health Organization (WHO) Guidance on Best Practices for Clinical Trials...
Good Clinical Trials Collaborative
Response to White House review – Emergency Clinical Trials
Good Clinical Trials Collaborative
The Collaborative responded to a recent call for input from the White House Office for Science & Technology Policy on how the U.S. and the world can mount a better clinical trials response to future health emergencies. Our response makes five recommendations on priority actions.